文献速递胃肠外科围术期管理与 ERAS

转换或修正代谢减重手术对阻塞性睡眠呼吸暂停的影响与费用:法国全国队列研究

Evaluating the impact and costs of conversional or revisional metabolic bariatric surgery on obstructive sleep apnea: Insights from a French nationwide cohort.
PubMed 文献 · Surgery · 2024-08-28

该法国全国观察性队列研究分析了2012至2014年接受初次代谢减重手术并随访至2020年的患者,评估5种转换或修正手术序列对持续气道正压通气治疗报销中断及费用的影响。结果显示各序列在术后4年持续气道正压通气中断率介于44.4%至78.2%,且年均治疗费用均显著低于修正手术前一年。

要点

  • 转换或修正减重手术可显著减少阻塞性睡眠呼吸暂停患者的持续气道正压通气需求及费用。
  • 术后4年持续气道正压通气中断率因手术序列不同,范围在44.4%至78.2%之间。
  • 各序列术后4年年均费用均显著低于修正手术前一年(P < .01)。

核心结论

  • 转换或修正代谢减重手术在4年内显著降低初次减重术后阻塞性睡眠呼吸暂停患者对持续气道正压通气的需求及相关费用。

研究设计与样本

  • 法国全国观察性人群队列研究,基于法国国家健康保险数据库,纳入2012年1月1日至2014年12月31日接受初次代谢减重手术的患者,随访至2020年12月31日。

主要发现

  • 随访期间共6396例患者接受5种转换或修正手术序列:袖状胃切除-胃旁路(n=2400)、可调节胃束带-袖状胃切除(n=2277)、可调节胃束带-胃旁路(n=1173)、袖状胃切除-袖状胃切除(n=546)、胃旁路-其他(n=332)。
  • 修正手术前一年阻塞性睡眠呼吸暂停率分别为15.2%、12.4%、15.5%、12.8%和9.9%。
  • 术后2年持续气道正压通气中断率分别为41.1%、41.9%、46.4%、29.3%和33.3%;术后4年分别为62.3%、57.0%、78.2%、57.5%和44.4%。
  • 术后4年各序列年均费用(欧元)均显著低于修正手术前一年(P < .01):526.9 ± 414.4 vs 257.4 ± 349.7;368.0 ± 247.5 vs 230.9 ± 288.4;433.7 ± 326.0 vs 116.8 ± 238.3;540.7 ± 275.3 vs 248.0 ± 308.4;501.2 ± 254.0 vs 281.1 ± 287.0。

临床怎么用

  • 对于初次减重术后仍存在阻塞性睡眠呼吸暂停并依赖持续气道正压通气的患者,转换或修正手术可作为减少通气需求及费用的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study assesses the effectiveness of 5 main conversional or revisional metabolic bariatric surgery sequences after sleeve gastrectomy, adjustable gastric banding and gastric bypass on reimbursement and cost of continuous positive airway pressure therapy, the first line treatment for obstructive sleep apnea, in France. METHODS: This nationwide observational population-based cohort study analyzed data from the French National Health Insurance database. It included all patients who had undergone primary metabolic bariatric surgery in France between January 1, 2012, and December 31, 2014, and followed until December 31, 2020. The study assessed continuous positive airway pressure therapy reimbursement discontinuation and costs of reimbursed continuous positive airway pressure therapy across 5 different conversional or revisional metabolic bariatric surgery sequences. RESULTS: During follow-up, 6,396 patients underwent the following sequences: sleeve gastrectomy-gastric bypass (n = 2,400), adjustable gastric banding-sleeve gastrectomy (n = 2,277), adjustable gastric banding-gastric bypass (n = 1,173), sleeve gastrectomy-sleeve gastrectomy (n = 546), and gastric bypass-others (n =332), with a rate of obstructive sleep apnea of 15.2%, 12.4%, 15.5% 12.8%, and 9.9% in the year before conversional or revisional metabolic bariatric surgery. The rates of patients who had a discontinuation of continuous positive airway pressure were at 2 and 4 years: 41.1%, 41.9%, 46.4%, 29.3%, and 33.3%; 62.3%, 57.0%, 78.2%; 57.5%, and 44.4%, respectively. At 4 years, the mean annual costs (euros) of obstructive sleep apnea treatment per patient were significantly lower (P < .01) than the costs in the year before conversional or revisional metabolic bariatric surgery for each sequence: 526.9 ± 414.4 vs 257.4 ± 349.7; 368.0 ± 247.5 vs 230.9 ± 288.4; 433.7 ± 326.0 vs 116.8 ± 238.3; 540.7 ± 275.3 vs 248.0 ± 308.4 and 501.2 ± 254.0 vs 281.1 ± 287.0, respectively. CONCLUSIONS: Our study underscore the effectiveness of conversional or revisional metabolic bariatric surgery in significantly reducing the need and associated costs of continuous positive airway pressure therapy for patients with obstructive sleep apnea postprimary metabolic bariatric surgery over a 4-year period.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Thereaux J, Bennani M, Khemis J, et al. Evaluating the impact and costs of conversional or revisional metabolic bariatric surgery on obstructive sleep apnea: Insights from a French nationwide cohort. Surgery. 2024. PMID: 39209610. doi:10.1016/j.surg.2024.07.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。